Hellström, V.C. et al. 2016. Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation – experiences from a prospective, clinical, observational study. Acta Oncologica. 55, 6 (Jun. 2016), 774–781. DOI:https://doi.org/10.3109/0284186X.2015.1130855.